HMP LinkerCAS# 68858-21-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 68858-21-9 | SDF | Download SDF |
PubChem ID | 6950808 | Appearance | Powder |
Formula | C9H10O4 | M.Wt | 182.2 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-[4-(hydroxymethyl)phenoxy]acetate | ||
SMILES | C1=CC(=CC=C1CO)OCC(=O)[O-] | ||
Standard InChIKey | VUCNQOPCYRJCGQ-UHFFFAOYSA-M | ||
Standard InChI | InChI=1S/C9H10O4/c10-5-7-1-3-8(4-2-7)13-6-9(11)12/h1-4,10H,5-6H2,(H,11,12)/p-1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
HMP Linker Dilution Calculator
HMP Linker Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.4885 mL | 27.4424 mL | 54.8847 mL | 109.7695 mL | 137.2119 mL |
5 mM | 1.0977 mL | 5.4885 mL | 10.9769 mL | 21.9539 mL | 27.4424 mL |
10 mM | 0.5488 mL | 2.7442 mL | 5.4885 mL | 10.9769 mL | 13.7212 mL |
50 mM | 0.1098 mL | 0.5488 mL | 1.0977 mL | 2.1954 mL | 2.7442 mL |
100 mM | 0.0549 mL | 0.2744 mL | 0.5488 mL | 1.0977 mL | 1.3721 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
HMP Linker
- Fmoc-Val-OH
Catalog No.:BCC3570
CAS No.:68858-20-8
- Boc-D-Tyr(Me)-OH
Catalog No.:BCC2597
CAS No.:68856-96-2
- Astemizole
Catalog No.:BCC7691
CAS No.:68844-77-9
- Xanthohumol L
Catalog No.:BCN8017
CAS No.:688360-15-8
- Xanthohumol I
Catalog No.:BCN8016
CAS No.:688360-06-7
- IWP 12
Catalog No.:BCC5622
CAS No.:688353-45-9
- 4-Epi-isoinuviscolide
Catalog No.:BCN4251
CAS No.:68832-39-3
- D-Prolinol(oil)
Catalog No.:BCC2708
CAS No.:68832-13-3
- Retusamine
Catalog No.:BCN2122
CAS No.:6883-16-5
- Sempervirine
Catalog No.:BCN4250
CAS No.:6882-99-1
- Sophoridine
Catalog No.:BCN4249
CAS No.:6882-68-4
- Dihydrochelerythrine
Catalog No.:BCN2273
CAS No.:6880-91-7
- 8-O-Methylretusin-7-O-beta-D-glucopyranoside
Catalog No.:BCN7899
CAS No.:68862-13-5
- Otonecine
Catalog No.:BCN2009
CAS No.:6887-34-9
- Eburicol
Catalog No.:BCN4252
CAS No.:6890-88-6
- Guaiacol salicylate
Catalog No.:BCC8327
CAS No.:87-16-1
- H-D-Glu-OH
Catalog No.:BCC2936
CAS No.:6893-26-1
- Kahweol
Catalog No.:BCC9006
CAS No.:6894-43-5
- SKF 91488 dihydrochloride
Catalog No.:BCC6675
CAS No.:68941-21-9
- Mulberrofuran A
Catalog No.:BCN3677
CAS No.:68978-04-1
- Uncarine A
Catalog No.:BCN7767
CAS No.:6899-73-6
- Quinacrine 2HCl
Catalog No.:BCC4709
CAS No.:69-05-6
- Chlorpromazine HCl
Catalog No.:BCC4460
CAS No.:69-09-0
- Ampicillin
Catalog No.:BCC1199
CAS No.:69-52-3
Improving the performance of an acid-labile 4-hydroxymethyl phenoxyacetic acid (HMP) linker on resin and SynPhase grafted solid-supports.[Pubmed:11071267]
J Pept Sci. 2000 Oct;6(10):534-8.
A replacement of the acetic acid moiety by valeric acid within the 4-hydroxymethylphenoxyacetic acid (HMP) linker (Sheppard RC, Williams BJ. Acid-labile resin linkage agents for use in solid phase peptide synthesis. Int. J. Peptide Protein Res. 1982; 20: 451-454) significantly improved its performance in terms of loading capacity, yield and purity of the final products. The results indicated the spacer-linker combination and type of solid supports are important factors for solid-phase synthesis.